Rheumatoid arthritis (RA) and osteoarthritis (OA) are the major types of arthritis. Although both diseases are characterized by joint destruction, their etiologies are different. To get insights into pathophysiological pathways, we used the suppression subtractive hybridization (SSH) method to identify differentially expressed genes in RA. DNA sequencing identified 12 gene products including cytoskeletal ␥-actin and extracellular matrix components such as fibronectin, collagen III␣ 1 , and superficial zone protein. Interferon ␥-inducible genes such as a novel thiol reductase, two genes of unknown function (HSIFNIN4, RING3), and annexin II were also found. Two genes encoded proteins involved in proliferation such as elongation factor 1␣ and the granulin precursor. Furthermore, the protease cathepsin B and synovial phospholipase A2 group IIA were detected by SSH. To confirm the differential expression of the genes, we performed RT-PCR analyses of RA and OA synovial tissues. Compared to OA patients, 9 of the 12 genes were overexpressed in RA, suggesting that SSH is a powerful tool for the detection of differential gene expression in synovial tissues. Further characterization of the gene products may help to identify pathophysiological mechanisms in arthritic diseases.
Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic inflammation, altered immune responses and hyperproliferation of the synovial lining, resulting in the progressive destruction of the affected joints (1) . The breakdown of cartilage and bone prevents joints from functioning normally. In severe cases, both cartilage and the underlying bone can be destroyed. A primary cause of their destruction involves elevated levels of active proteases which are secreted from a variety of cells and degrade collagen and proteoglycans. The cellular sources of the proteases depend on the type of disease. Several interconnected events taking place in the synovial membrane are considered to play a major role for the initiation of the destructive process (2) . These include (i) formation of endothelial venules and expression of adhesion molecules, which facilitate the trafficking of T-cells and other leukocytes into the synovium, (ii) stimulation of macrophages, which not only produce a large number of biologically active substances, but also play a key role in the immune response as antigen-presenting cells, and (iii) angiogenesis induced by macrophages and fibroblasts with simultaneous pannus formation (2) (3) (4) (5) (6) .
The interactions between synoviocytes, macrophages, polymorphonuclear leukocytes and chondrocytes are involved in the final destruction of cartilage in RA. The aggressive and transformed synovial fibroblasts serve as the primary source of factors that mediate joint inflammation and lead to direct tissue destruction through the production of metalloproteinases, cathepsins and adhesions molecules, such as vascular cell adhesion molecule-1 (VCAM-1), at the pannus-cartilage interface (7) . Abundant leukocytes within the synovial fluid release large amounts of neutral metalloproteinases together with lysosomal enzymes, which saturate and overwhelm the capacity of protease inhibitors in the synovial fluid and cartilage matrix. The production of oxygen radicals by leuko-cytes is believed to further contribute to this process by degrading hyaluronic acid, inactivating protease inhibitors and inducing the synthesis of chemotactic factors (2) . The complete pathway starts with the stimulation of synovial fibroblasts by cytokines and activated macrophages, followed by the upregulation of protooncogenes and tyrosine kinases and subsequent activation of gene expression. There is increasing evidence that chronic inflammatory diseases such as RA are caused by the prolonged production of proinflammatory cytokines, especially TNF-␣. The importance of TNF-␣ was first demonstrated by elevated levels of the cytokine in dissociated rheumatoid joint cell cultures, then substantiated in animal models of arthritis and finally proven by the success of clinical trials of anti-TNF-␣ antibodies or neutralizing receptor decoy proteins (8) .
Although, similarly to RA, osteoarthritis (OA) is characterized by the degradation of the joint architecture, both arthritic diseases have a distinct pathogenesis (5, 9) . OA is a primarily degenerative process, typically occurring in people more than 60 years of age and involving local cartilage destruction. In contrast, a characteristic feature of RA is the propensity of the synovium to become locally invasive at its cartilage interface and a systemic inflammatory disease that results in symmetrical joint inflammation along with other constitutional symptoms.
The cellular composition and pathways of cell activation in RA have been analyzed in detail. However, in most studies cells lines derived from rheumatoid synoviocytes have been used, which in culture may not reflect the true cellular phenotype present in the affected joints. Therefore, in order to gain insights into the biology of joint inflammation, we decided to look for genes that are differentially expressed in synovial tissues of RA and OA patients. To this end, we employed a differential subtraction method, called suppression subtractive hybridization (SSH) (10) , and found several genes which, compared to OA tissues, are constitutively overexpressed in RA synovia.
MATERIALS AND METHODS

Synovial Specimens and Tissue RNA Extraction
Synovial tissue was obtained during therapeutic synoviectomy from 14 RA patients who met the revised criteria of the American College of Rheumatology (11) . In addition, 12 synovial specimens were obtained from patients with OA. RA patients (2 males, 12 females) had a mean age of 59.7 years (range 37-79). The mean duration of the disease was 17.3 years (range 4 -35) . OA patients (2 males, 10 females) had a mean age of 67.8 years (range 54 -79). All RA patients were treated with various antirheumatic drugs (antimalarials, methotrexate, azathioprine, glucocorticoids or gold derivatives). OA patients were treated with nonsteroidal antirheumatic drugs. Synovial samples were directly frozen in liquid nitrogen and histologically examined. For RNA extraction the samples were treated mechanically in dry ice until powdered, transferred into TRI-reagent (Sigma, Deisenhofen, Germany) and sonicated for 15 s. RNA quantification was performed by spectrophotometry, and the integrity of the RNA was examined by electrophoresis on a 1.2% agarose gel stained with ethidium bromide.
Suppression Subtractive Hybridization
Poly(A) ϩ RNA was isolated from a patient with RA and a patient with OA from 500 -1000 g of total RNA using a poly-(dT) column (Pharmacia Biotech, Freiburg, Germany). The yield was 5-10 g poly(A) ϩ RNA. The integrity of the mRNA was controlled by agarose electrophoresis. The SSH was performed with the PCR-Select cDNA subtraction kit (Clontech, Palo Alto, CA) as described previously (10, 12) . The first and second strand cDNA was synthesized from 1 g of each mRNA (RA and OA) according to standard protocols.
To obtain shorter blunt-ended molecules, the cDNA was digested with RsaI. Following DNA precipitation adaptors were ligated to the digested RA cDNA as follows: 1 l of the cDNA were diluted in 5 l dH 2 O. Two l of the diluted RA cDNA were ligated to adaptor A and 2 l were ligated to adaptor B at 16°C overnight using T4 DNA ligase. The first hybridization was performed in two steps: (1) with the adaptor A-ligated RA cDNA and the undiluted OA RSA I digested cDNA, and (2) with the adaptor B-ligated RA cDNA and the undiluted OA RsaI-digested cDNA for 8 h at 68°C. The second hybridization was followed by mixing both hybridized portions with freshly denaturated RsaIdigested OA cDNA and further incubation at 68°C overnight.
A primary PCR was used to selectively amplify the differentially expressed sequences and performed with 1 l of the diluted subtracted cDNA in a 25 l-volume containing 400 nM of each primer, 0.2 mM dNTPs, and 0.5 l of Advantage KlenTaq polymerase mix (Clontech). The PCRs were performed in a thermal cycler with the following parameters: 75°C for 7 min, 30 cycles at 94°C for 30 s, 68°C for 30 s, and 72°C for 1.5 min. Then, 1 l of the amplified product was used as a template in secondary PCR for 30 cycles with nested adaptor-specific primers under the following conditions: 94°C for 30 s, 68°C for 30 s, and 72°C for 1.5 min.
Detection, Cloning and Sequencing of Subtracted cDNA Fragments
Subtracted cDNA fragments were detected by horizontal polyacrylamide electrophoresis. 7 l of the amplified cDNA were separated on a long-run gel in three slots. The gel was subsequently cut in the second lane and the first part was stained with silver. Distinct visible bands were excised from the unstained part of the gel and used as a template for another PCR. The products of the reamplified cDNA fragments were then inserted into the pCR2.1 cloning vector (TOPO-TA Cloning-Kit, Invitrogen, Carlsbad, CA) and transformed in Top F10Ј cells (Invitrogen). The bacteria were plated on ampicillin-containing agar plates, which were overlaid with 1.4 g ␤-X-Gal and 100 M IPTG. After overnight incubation white colonies were picked and transferred into wells of a multititer plate with 200 l LB medium and subsequently incubated for 4 h at room temperature. The bacteria were lysed by heating to 100°C for 10 min and 5 l of each sample were used to amplify the cloned inserts in 50 l reactions using standard PCR conditions and M13 sequencing primers. An aliquot of the PCR products was loaded on a horizontal polyacrylamide gel to confirm the correct size of the cloned fragment. DNA sequencing was performed by automated means at MWG-Biotech (Ebersberg, Germany). Nucleic acid homology searches were performed using the BLAST program (13) .
Reverse Transcription (RT)-PCR of Detected Sequences
To confirm the differential expression of the detected sequences, RT-PCR analyses were performed. 5Ј-and 3Ј-primers were designed for each of the detected sequences and synthesized by MWG-Biotech. PCR conditions were optimized by varying the annealing temperature and time as well as the Mg 2ϩ and K , and 40 cycles samples were removed and loaded onto ethidium bromide stained agarose gels. The bands were cut out under UV-light and melted in 500 l H 2 O. The relative amounts of amplified DNA were determined by Cerenkov counting and plotted as a function of the number of cycles. Densitometric analyses were performed on a two-dimensional scanning densitometer (Biometra, Göttingen, Germany) using the ScanPack software version 14.1A27. The ethidium bromide-stained gels were photographed and the densitomeric results of gene expression were standardized to that of GAPDH expression in the same sample according to Ko et al. (14) . GAPDH transcripts were amplified in 25 PCR cycles. The ratio of the relevant expression profile versus the GAPDH profile was set to 100%. Statistical analysis of data was performed using the Mann-Whitney U test (15) .
RESULTS
In an effort to identify genes that may be expressed differentially in synovial tissue from RA and OA patients, we employed the SSH approach. The mRNA from the synovium of a patient with clinically and histogically confirmed RA (tester) and the mRNA of a OA synovium (driver) were isolated, reverse transcribed into cDNA and digested with RsaI. For the SSH procedure two different adaptors were separately ligated to the digested tester cDNA. After the first hybridization of the two different tester cDNAs with an excess of denaturated driver cDNA in separate samples and a second hybridization step, the subsequent PCR amplification was performed without denaturation. Following polyacrylamide electrophoresis subtracted cDNA fragments of different size were detected by silver staining (Fig. 1A) . The visible subtracted cDNA fragments were excised from the gel and reamplified. As shown in Fig. 1B, 9 discrete cDNA bands could be resolved by this procedure. The reamplified cDNA fragments were inserted into a cloning vector and sequenced using M13 primers. As three bands of the polyacrylamide gene (lanes 5-7) each contained two sequences of similar size, 12 different cDNA sequences were obtained ( Table 1 ). The sequences were aligned to the sequence databases using the BLAST program.
The genes identified by SSH could be classified into different groups. Four of the genes encoded structural proteins including cytoskeletal ␥-actin and the extracellular matrix components fibronectin, collagen III␣ 1 and superficial zone protein (SZP), which is a large proteoglycan located at the synovial lining (16) . SZP has been recently found as the gene mutated in CACP, a disease characterized by synovial and intimal hyperplasia (17) . Two of the genes found were involved in the regulation of proliferative events including elongation factor ␣1 and the precursor of granulins (epithelins). Granulins are small proteins which can modulate the growth of several cell types (18, 19) . Two other genes found have been originally identified as interferon (IFN)-␥ inducible genes, including the novel lysosomal thiol reductase GILT (20) and HSIFNIN4, a gene of unknown function (21) . Furthermore, the cysteine protease cathepsin B and phospholipase A2 group IIA, which was originally identified in synovial fluid of in-flammatory arthritis (22) , were identified by SSH. Finally, we detected the genes for annexin II, a member of a family of Ca 2ϩ -and phospholipid-binding proteins (23) , as well as RING3, a gene located in the MHC complex (24) .
To investigate whether the subtracted genes were indeed differentially overexpressed in RA synovium, detailed RT-PCR analyses were performed. We collected synovia from 13 patients with RA and 11 patients with OA and isolated RNA from these samples. For all genes detected by SSH a RT-PCR was established using the primers mentioned in Table 2 . To obtain semi-quantitative results, the number of the cycles of each RT-PCR, which was required for exponential DNA amplification, was first determined. The relative quantities of the specific PCR products were then determined by densitometric analysis and normalized with the density of the GAPDH profiles. As demonstrated in Table 3 , most genes were indeed strongly upregulated in RA synovium and significantly less expressed in tissue samples from OA patients. Exceptions were the genes coding for RING3, the IFN-␥ inducible gene HSIFNIN4 and synovial phospholipase A2. For synovial phospholipase A2 a significantly higher gene expression was obtained in RA patients, if one patient with an exceptionally low signal was excluded. Representative examples of the comparative RT-PCR and densitometric analyses from patients with RA and OA are shown in Fig. 2 . Except from a few patients, the genes for fibronectin, annexin II, GILT and cathepsin B were significantly upregulated in all RA samples. Thus, these results reveal that most genes identified by SSH were indeed differentially expressed in RA synovial tissues.
DISCUSSION
The objective of the present study was to identify genes that are specifically upregulated in RA and less expressed in OA synovial tissues. The SSH technique used in this study was originally developed as a PCRbased cDNA subtraction method which selectively amplifies differentially expressed cDNA fragments, while simultaneously suppressing amplification of cDNAs of equal abundance (10) . Using this method we detected 12 subtracted genes, from which 9 were indeed constitutively overexpressed in RA synovium. Some of the genes identified have been already implicated in the pathogenesis of RA, supporting the validity of our differential hybridization approach for the study of synovial gene expression. In fibroblasts these signals include modulation of metalloproteinase production and cellular growth, whereas in lymphocytes interaction of fibronectin with integrin receptors, such as VLA-4, results in costimulatory activity (25, 26) . Indeed, it has been shown that the fibronectin concentration is significantly higher in synoival fluids from patients with RA than in other rheumatic diseases (27) . Large amounts of fibronectin mRNA were found specifically in synovial lining cells. It has also been suggested that the expression of fibronectin partially correlates with cell proliferation in the synovial lining in RA (28) . 5Ј-CTTCTAAACGGACTCAGCAG-3Ј   25   6a  SZP  5Ј-GGAGAAACGACACAGGTTAG-3Ј  5Ј-CTCTTGCTGTTCTACTAGGC-3Ј   22   6b  PLA2G2A  5Ј-GTACGGCTTCTTTGGTTAAGC-3Ј  5Ј-CCTAACCAAGTTCCTTGGCC-3Ј   27   7a  GRZ  5Ј-CAGGTACTGAAGACTCTGCA-3Ј  5Ј-CTGTGGATAGGGAAAAGCAC-3Ј   28   7b  RING3  5Ј-GGCACGAAAGCTACAGGATG-3Ј  5Ј-GTTCCTGTAGTTCTGCTAAG-3Ј   27   8  ANX2  5Ј-GAAATGGTGCTCACCATGCTT-3Ј  5Ј-GACTTCACTTCCAACTCCTTG-3Ј   27   9  CTSB  5Ј-GGTACACTCCTGACTTGTAG-3Ј  5Ј-CAAGTGTAGCAAGATCTGTG-3 In view of the characteristic hyperproliferation of synoviocytes in RA it was not surprising to find that some of the detected genes were involved in the regulation of cell growth. A significant increase in the mRNA level of elongation factor 1␣ is usually observed in all highly proliferative cells (29) . An interesting finding was the detection of the precursor of granulins (epithelins). Granulins were originally isolated from inflammatory cell exudates as small proteins derived from a single precursor molecule (18, 19) . Both the precursor and the processed granulins have growthmodulatory activity. Recently, it has been demonstrated that overexpression of the progranulin gene in epithelial carcinoma cells resulted in increased clonogenicity and cell proliferation, whereas diminution of progranulin expression impaired cell growth (30, 31) . It was suggested that the rate of growth of some epithelia is proportional to the level of intrinsic progranulin gene expression, and that elevated progranulin expression confers a transformed phenotype on epithelial cells. It is noteworthy that also annexin II, which was identified in this study, has been implicated in DNA synthesis and regulation of cell growth (32) . Increased annexin II levels have been detected in RA synovium (33) . Thus, it will be interesting to investigate whether granulins and annexin II are involved in the invasive growth of RA synoviocytes.
Two of the identified genes were IFN-␥ inducible molecules, such as HSIFNIN4, a gene of unknown function, and GILT which encodes a lysosomal thiol reductase. GILT has been originally described as IP-30 and found to be strongly inducible in primarily monocytes (34) . Currently, it is unknown whether GILT has an immunological function, but it is striking that it is highly expressed in active antigen-presenting cells, where it colocalizes with intracellular MHC class II molecules (20) . Nonetheless, the identification of IFN-␥ inducible genes reflects the presence of an activated phenotype of the RA synovium.
A potential role for IFN-␥ in RA is underscored by the finding of cathepsin B and the synovial phospholipase A2 in our screen. A recent study demonstrated a selective induction of cathepsins B by IFN-␥ in macrophages (35) . Similar effects of IFN-␥ on the secretion of cathepsin B secretion have been found in synovial fibroblast-like cells (36) . Cysteine proteinases such as cathepsin B are able to cleave collagen and various other proteoglycans. In addition to its direct degrading function, cathepsin B may act as an activator of metalloproteinases, such as the fibroblast-type interstitial collagenases (37) . Cathepsin B has been found to be highly expressed in perivascular infiltrates and endothelial cells of early arthritis tissue (38) , implying a potential role for the onset of joint destruction. It has been reported that the expression of cathepsin B is significantly more prominent in RA synovial lining compared to OA tissues (39) . Similarly, also elevated levels of synovial phospholipase A2, which is the major phospholipase expressed in RA synovial fluid, correlated with the activity of inflammatory arthritis (40) .
During our study we noticed that overexpression of some genes with an established role in the pathogenesis of RA, such as for instance TNF-␣ or VCAM-1, was not detected by the SSH approach. Several reasons may account for this failure. First, in the SSH procedure the restriction enzyme RsaI was used to create relatively small cDNA fragments in order to facilitate efficient amplification by PCR. The absence of RsaI sites may explain, why some genes may escape detection by the SSH procedure. Second, an important determinant for the completeness of the gene subtraction and the possibility to detect genes, which only differ weakly in expression levels, is the ratio of the tester and driver cDNA in the SSH reaction. Thus genes, which are only weakly overexpressed in RA compared to OA synovium, may not be identified. In this context, it is noteworthy that TNF-␣ and a number of other cytokines have been found to be expressed to similar levels in RA and OA synovia (41) . Nevertheless, most products identified in our study are involved in matrix remodeling and tissue destruction, suggesting that these events may play a primary and essential role in RA pathogenesis. Further studies have to characterize the cellular distribution and the regulation of these gene products in different stages of rheumatic diseases.
FIG. 2.
Representative examples of RT-PCR analyses of synovium from RA and OA patients. Analyses for fibronectin, annexin II, GILT, and cathepsin B are shown. Total RNA was isolated from synovium of 13 RA and 10 OA patients. RT-PCR was performed with the specific primers indicated in Table 2 . As a control for the same amount of RNA, a RT-PCR with GAPDH primers was performed. The relative quantities of the specific PCR products were determined by densitometric analysis and normalized with the density of the GAPDH profiles (lower panels). A molecular size marker (M) consisting of HaeIII digested ⌽⌾-174 DNA is shown on the right.
